Absorption, Metabolism, and Excretion of Quizartinib (AC220), a FLT3 Tyrosine Kinase Inhibitor for Treatment of Acute Myeloid Leukemia, in Healthy Male Volunteers - Li, Jianke; Bresnahan, Gayle; Gammon, Guy; Sanga, Madhu; Hale, Christine; Hashimoto, Tadashi; Gill, Stanley; James, Joyce (Blood, 2012)